Drug Chatter -- Tracking biopharma stock chatter

Profile for Oncothyreon Inc. (ONTY)

« Back to company index

ONTY Chatter Timeline

Stock Ticker for ONTY

Most Active Tweeters for ONTY

UserTweets
@confcalltran 2

Recent Tweets for ONTY

confcalltran @confcalltran
Oncothyreon: Cascadian Therapeutics, Inc. 8-K https://t.co/XdJp4hIYy0 $ONTY
November 9th 2017, 7:11am
confcalltran @confcalltran
Oncothyreon Inc. Just Filed Its Quarterly Report: https://t.co/ZJyAgIwD7I ... https://t.co/G7x2ytodDp $ONTY
November 9th 2017, 6:11am
specstockspulse @specstockspulse
Get your say in on $ONTY at SpeculatingStocks, the discovery engine. No login required! #stocks https://t.co/UFgTqsCMbC
October 13th 2017, 3:10am
confcalltran @confcalltran
Oncothyreon Inc. director just picked up 1,781 shares https://t.co/iCqwlWZkNY $ONTY
September 26th 2017, 5:09pm
confcalltran @confcalltran
Oncothyreon Inc. director just picked up 1,781 shares https://t.co/Gai3WjQgaa $ONTY
September 26th 2017, 5:09pm
confcalltran @confcalltran
Oncothyreon Inc. director just picked up 1,781 shares https://t.co/ErMuwmzKK0 $ONTY
September 26th 2017, 5:09pm
QLFilings @QLFilings
$ONTY filed Form 4 with the SEC. Most mentioned words: vesting, seattle, therapeutics, cascadian, approximately
September 20th 2017, 10:09pm
QLFilings @QLFilings
$ONTY filed Form 4 with the SEC. Most mentioned words: vesting, seattle, fourth, approximately, holder's
September 20th 2017, 10:09pm
confcalltran @confcalltran
Oncothyreon Inc.'s Chief Operating Officer was just granted 83,000 options and restricted share https://t.co/WappUSHeCf $ONTY
September 20th 2017, 9:09pm
confcalltran @confcalltran
Oncothyreon Inc.'s President and CEO was just granted 75,500 options and restricted shares https://t.co/x6t0Oh4fvJ $ONTY
September 20th 2017, 9:09pm
biotech_sector @biotech_sector
#CascadianTherapeutics Release: Tucatinib Data In Multiple Tumor Types Presented At The . Read more: https://t.co/799LbeP2pR $ONTY
September 11th 2017, 4:09pm
biotech_sector @biotech_sector
#CascadianTherapeutics Tucatinib Data in Multiple Tumor Types Presented at the European Soc... Read more: https://t.co/sYx2Bk6JAb $ONTY
September 11th 2017, 11:09am
biotech_sector @biotech_sector
#CascadianTherapeutics Tucatinib Data in Multiple Tumor Types Presented at the European Soc... Read more: https://t.co/5pbxJ7VODC $ONTY
September 11th 2017, 8:09am
biotech_sector @biotech_sector
#CascadianTherapeutics Tucatinib Data in Multiple Tumor Types Presented at the European Soc... Read more: https://t.co/JL6bgcmA6W $ONTY
September 11th 2017, 8:09am
biotech_sector @biotech_sector
#CascadianTherapeutics Inc CASC Pharmaceuticals Healthcare Deals and Alliances Profile R... Read more: https://t.co/AfqfwZ3tWp $ONTY
September 8th 2017, 12:09pm
biotech_sector @biotech_sector
#CascadianTherapeutics (CASC) Announces Poster Presentations on Tucatinib in Multiple Tumor... Read more: https://t.co/KkPl6SgBBE $ONTY
September 8th 2017, 12:09pm
biotech_sector @biotech_sector
#CascadianTherapeutics Inc CASC Pharmaceuticals Healthcare Deals and Alliances Profile R... Read more: https://t.co/JFLTp0nHFr $ONTY
August 28th 2017, 5:08am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.